Completed NA INTERVENTIONAL 1-arm NCT04729647

Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer

Immature Granulocyte Count and Delta Neutrophil Index as New Predictive Factors for Axillary Metastasis of Breast Cancer

Sponsor: Kahramanmaras Sutcu Imam University

Conditions Breast Cancer Breast Cancer Invasive

Interventions Mastectomy

Updated 4 times since 2021 Last updated: Jan 28, 2021 Started: Feb 28, 2015 Primary completion: Feb 29, 2020 Completion: Feb 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Breast Cancer Invasive and is currently completed. Kahramanmaras Sutcu Imam University leads this study, which shows 4 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2021 — Jul 2024 [monthly]

Completed NA
Feb 2021 — Mar 2021 [monthly]

Completed NA

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kahramanmaras Sutcu Imam University

Data source: Kahramanmaras Sutcu Imam University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.